Scarica l'app Stockscreener
2.125
1.68%
0.045
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PACB Giù?
Forum
Previsione
Precedente Chiudi:
$2.08
Aprire:
$2.07
Volume 24 ore:
7.77M
Relative Volume:
0.89
Capitalizzazione di mercato:
$641.55M
Reddito:
$188.87M
Utile/perdita netta:
$-400.38M
Rapporto P/E:
-1.4167
EPS:
-1.5
Flusso di cassa netto:
$-260.90M
1 W Prestazione:
+13.10%
1M Prestazione:
-11.51%
6M Prestazione:
+43.88%
1 anno Prestazione:
+5.75%
Intervallo 1D:
$2.0517
$2.22
Intervallo di 1 settimana:
$1.79
$2.22
Portata 52W:
$0.8511
$2.725
Pacific Biosciences Of California Inc Stock (PACB) Company Profile
Nome
Pacific Biosciences Of California Inc
Settore
Industria
Telefono
650-521-8000
Indirizzo
1305 O'BRIEN DRIVE, MENLO PARK, CA
Confronta PACB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PACB
Pacific Biosciences Of California Inc
|
2.125 | 627.97M | 188.87M | -400.38M | -260.90M | -1.50 |
|
ABT
Abbott Laboratories
|
127.08 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.65 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.92 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.81 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.78 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-11 | Downgrade | UBS | Buy → Neutral |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-22 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-04-18 | Downgrade | Goldman | Buy → Neutral |
| 2023-12-14 | Iniziato | Guggenheim | Neutral |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-11-17 | Aggiornamento | UBS | Neutral → Buy |
| 2023-10-31 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-06-30 | Iniziato | Goldman | Buy |
| 2023-05-10 | Iniziato | Barclays | Equal Weight |
| 2023-03-31 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-02-02 | Iniziato | UBS | Neutral |
| 2023-01-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-01-21 | Ripresa | Cantor Fitzgerald | Overweight |
| 2022-01-06 | Ripresa | Piper Sandler | Neutral |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-09-27 | Iniziato | Canaccord Genuity | Buy |
| 2021-02-11 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-11-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-10-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-06-02 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-03-09 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-10-15 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-04-02 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2018-10-19 | Iniziato | Cowen | Outperform |
| 2017-11-03 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-28 | Downgrade | CL King | Buy → Neutral |
| 2016-11-03 | Reiterato | Cantor Fitzgerald | Buy |
| 2016-06-27 | Iniziato | CL King | Buy |
| 2016-04-15 | Iniziato | First Analysis Sec | Overweight |
| 2016-02-04 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2016-01-04 | Reiterato | Cantor Fitzgerald | Buy |
| 2015-10-23 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2015-08-27 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-02-04 | Reiterato | Maxim Group | Buy |
| 2013-09-26 | Reiterato | Maxim Group | Buy |
| 2013-01-14 | Reiterato | Maxim Group | Buy |
Mostra tutto
Pacific Biosciences Of California Inc Borsa (PACB) Ultime notizie
Here's Why You Should Add PacBio Stock to Your Portfolio - Yahoo Finance
What analysts say about Pacific Biosciences of California Inc stockOptions Trading Strategies & Low Entry Cost Trading - earlytimes.in
Three Genomics Stocks Worth Tracking This Year - Nasdaq
We Think Pacific Biosciences of California (NASDAQ:PACB) Has A Fair Chunk Of Debt - simplywall.st
What drives Pacific Biosciences of California Inc P09 stock priceMarket Volatility Update & Missed Nvidia? Don’t Miss This One - earlytimes.in
Retail Surge: Will Pacific Biosciences of California Inc P09 stock rise with strong economyJuly 2025 Volume & Low Risk Entry Point Tips - moha.gov.vn
Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24 - The Globe and Mail
PacBio (PACB) Stock Is Up, What You Need To Know - Finviz
Pacific Biosciences of California (NASDAQ:PACB) Shares Gap UpTime to Buy? - MarketBeat
What analysts say about Pacific Biosciences of California Inc P09 stockTechnical Resistance Breaks & Outstanding Capital Returns - earlytimes.in
Stocks making big moves yesterday: FuelCell Energy, Corcept, and PacBio - The Globe and Mail
Why Is PacBio (PACB) Stock Soaring Today - Finviz
Cathie Wood’s Strategic Move: ARK Investment Buys PacBio Shares - StocksToTrade
Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks - Benzinga
Pacific Biosciences of California (NASDAQ:PACB) Shares Up 7.1%Should You Buy? - MarketBeat
Cathie Wood’s ARK Investment Fuels PacBio Stock Surge - timothysykes.com
Barclays Analyst Is Bullish On Pacific Biosciences of California, Inc. (PACB) - Finviz
PacBio to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
12 Best Genomics Stocks to Invest In - Insider Monkey
Pacific Biosciences of California (NASDAQ:PACB) Shares Down 5.1%What's Next? - MarketBeat
Cathie Wood’s ARK buys Weride, Pacific Biosciences stocks, sells Ibotta By Investing.com - Investing.com Nigeria
ARK Investment Acquires Additional Shares of PacBio (PACB) - GuruFocus
Cathie Wood’s ARK buys Weride, Pacific Biosciences stocks, sells Ibotta - Investing.com
ARK Investment Acquires Significant Stake in PacBio (PACB) - GuruFocus
Pacific Biosciences unveils gift campaign with coffee subscription giveaway - Traders Union
Pacific Biosciences of California Target of Unusually Large Options Trading (NASDAQ:PACB) - MarketBeat
Will Pacific Biosciences of California Inc. stock maintain dividend yieldJuly 2025 Decliners & Fast Moving Stock Watchlists - Улправда
Is Pacific Biosciences of California Inc. (P09) stock ideal for retirement investorsMarket Growth Review & Technical Entry and Exit Tips - ulpravda.ru
How Pacific Biosciences of California Inc. stock valuations compare to rivalsInsider Selling & Long-Term Investment Growth Plans - Улправда
Pacific Biosciences of California (HAM:P09) EV-to-OCF : -7.32 (As of Dec. 20, 2025) - GuruFocus
What insider trading reveals about Pacific Biosciences of California Inc. stockQuarterly Portfolio Review & Weekly High Return Forecasts - Улправда
Aug Mood: What insider trading reveals about Pacific Biosciences of California Inc. stock - Улправда
What technical charts say about Pacific Biosciences of California Inc. stock2025 Trading Volume Trends & Real-Time Sentiment Analysis - DonanımHaber
How Pacific Biosciences of California Inc. stock reacts to Fed rate cutsPortfolio Growth Summary & Free Safe Entry Trade Signal Reports - DonanımHaber
Can Pacific Biosciences of California Inc. stock double in next 5 years2025 Macro Impact & AI Based Buy/Sell Signal Reports - Улправда
Is Pacific Biosciences of California Inc. stock a defensive play in 2025GDP Growth & Weekly High Momentum Picks - Улправда
Highs Report: Is Pacific Biosciences of California Inc. stock a defensive play in 2025 - ulpravda.ru
Quarterly Risk: Will Pacific Biosciences of California Inc. stock maintain dividend yield2025 Growth vs Value & High Win Rate Trade Tips - Улправда
US Market Wrap: Will Pacific Biosciences of California Inc. stock pay special dividendsPortfolio Risk Report & Pattern Based Trade Signal System - Улправда
Is Pacific Biosciences of California Inc. stock safe for conservative investorsWeekly Trading Summary & Free Expert Verified Stock Movement Alerts - Улправда
Pacific Biosciences: Longer Reads, But Shorter Patience (Downgrade) (PACB) - Seeking Alpha
What technical signals suggest for Pacific Biosciences of California Inc. stockOptions Play & AI Forecasted Stock Moves - Улправда
How risky is Pacific Biosciences of California Inc. stock now2025 Fundamental Recap & Weekly Market Pulse Updates - Улправда
MACD Signal: Can Pacific Biosciences of California Inc. stock double in next 5 yearsWeekly Trade Recap & Free Risk Controlled Daily Trade Plans - ulpravda.ru
Barclays Maintains Pacific Biosciences of California (PACB) Equal-Weight Recommendation - Nasdaq
Barclays Maintains Rating and Increases Price Target for PACB | - GuruFocus
Pacific Biosciences Of California Inc Azioni (PACB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.20%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):